Fundraising Fox

Wouter Joustra

InvestorFounder

General Partner at Forbion · Board director at Navigator Medicines

Amsterdam, Netherlands

Writes $100K – $5M checks · typically $1.5M

FoundedNavigator Medicines

About

Wouter Joustra is a General Partner at Forbion, which he joined in 2019, where he works on deal origination, portfolio management, and divestment strategies with a focus on the firm's Growth Opportunities Funds targeting late-stage life sciences companies. He previously served as a Senior Trader and Executive Board member of the life sciences franchise at the investment bank Kempen. He holds an M.Sc. in Business Administration and a B.Sc. in International Business and Management, both from the University of Groningen.

Invests in

Biotech

Board director at Navigator Medicines

Intro paths

In turn, Wouter can intro founders to Navigator Medicines's investors below.

Co-founders at Navigator Medicines

NM
NAVEEN MANU DARYANIExecutive Officer
SB
STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
WD
WILLIAM DALEY BONIFICIOExecutive Officer, Promoter

Experience

  1. Vor BioMember Board of Directors (NASDAQ: VOR)current2025 — present
  2. Verdiva BioMember Board of Directors & Founding Investorcurrent2025 — present
  3. Navigator Medicines, Inc.Member Board of Directorscurrent2024 — present
  4. Beacon TherapeuticsMember Board of Directorscurrent2024 — present
  5. NewAmsterdam Pharma CorporationMember Board of Directors (NASDAQ: NAMS)current2024 — present
  6. NewAmsterdam Pharma CorporationBoard Member (Observer) (NASDAQ: NAMS)2021 — 2024
  7. enGeneMember Board of Directors (NASDAQ: ENGN)current2024 — present
  8. VectorYMember Board of Directorscurrent2023 — presentAmsterdam, North Holland, Netherlands
  9. ForbionGeneral Partnercurrent2020 — present
  10. ForbionFEAC Board Director (NASDAQ now: ENGN)2021 — 2023
  11. ForbionPartner2019 — 2020The Randstad, Netherlands
  12. Aiolos BioBoard Member & Founding Investor - Sold to GSK for up to $1.4bn2023 — 2024San Francisco, Californië, Verenigde Staten
  13. VectivBio AGBoard Member (NASDAQ: VECT) - Sold to Ironwood for $1.2bn2022 — 2023
  14. Gyroscope TherapeuticsBoard Member - Sold to Novartis for up to $1.5bn2021 — 2022
  15. Van Lanschot Kempen Investment BankingExecutive Boardmember Life Sciences Franchise2017 — 2019Amsterdam, North Holland, Netherlands
  16. Van Lanschot Kempen Investment BankingSenior Life Sciences Trader2016 — 2019The Randstad, Netherlands
  17. Da Vinci DerivativesDerivatives Trader2016Amsterdam
  18. Kempen & CoTrader2013 — 2016Amsterdam Area, Netherlands
  19. Kempen & CoEquity Research Analyst2013The Randstad, Netherlands

Education

  1. University of GroningenMSc Business Administration2011 — 2013
  2. University of Nebraska at OmahaBSc Economics2010 — 2011
  3. University of GroningenBSc International Business and Management2007 — 2011
  4. College HageveldPre-university education (VWO), Science and Engineering2000 — 2007

Deals · 2

Navigator MedicinesBoard seat

via Forbion · filed Sep 2024 · $100M raise

Gyroscope Therapeutics LtdBoard seat

via Forbion · filed Apr 2021 · $148M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Forbion

Frequently asked questions

Where does Wouter Joustra work?
Wouter Joustra is General Partner at Forbion and Founder at Navigator Medicines.
What does Wouter Joustra invest in?
Wouter Joustra invests in Biotech.
What check size does Wouter Joustra write?
Wouter Joustra typically writes checks of $100K – $5M.
What companies did Wouter Joustra found?
Wouter Joustra founded Navigator Medicines.

Same school

Shared employers